Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction-Reference-Cited by-同舟云学术

Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction

Published:2018-11 Issue: Volume:271 Page:132-139
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Streng Koen W.,Nauta Jan F.,Hillege Hans L.,Anker Stefan D.,Cleland John G.,Dickstein Kenneth,Filippatos Gerasimos^ORCID,Lang Chim C.,Metra Marco^ORCID,Ng Leong L.,Ponikowski Piotr,Samani Nilesh J.,van Veldhuisen Dirk J.,Zwinderman Aeilko H.,Zannad Faiez,Damman Kevin,van der Meer Peter,Voors Adriaan A.

Funder

Dutch Heart Foundation

European Commission

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Co-morbidities in heart failure;van Deursen;Heart Fail. Rev.,2014

2. Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure;Braunstein;J. Am. Coll. Cardiol.,2003

3. Comorbidity-adjusted relative survival in newly hospitalized heart failure patients: a population-based study;Baldi;Int. J. Cardiol.,2017

4. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey;van Deursen;Eur. J. Heart Fail.,2014

5. Non-cardiac comorbidities in chronic heart failure;Lang;Heart,2007

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study;Clinical Research in Cardiology;2024-09-11

2. Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review;Frontiers in Cardiovascular Medicine;2024-09-06

3. Plasma myo-inositol elevation in heart failure: clinical implications and prognostic significance. Results from the BElgian and CAnadian MEtabolomics in HFpEF (BECAME-HF) research project;eBioMedicine;2024-09

4. Long-term risk predictors of adverse events in patients with chronic heart failure;Science and Innovations in Medicine;2024-07-26

5. CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and kidney dysfunction;Clinical Kidney Journal;2024-07-02